HPAI Alert: Bird Flu Cases Soar Across the U.S.
Avian influenza is back in the spotlight, and veterinary professionals across the country are paying close attention. Cases of Highly Pathogenic Avian Influenza (HPAI) are on the rise in the U.S., impacting commercial and backyard flocks alike. Understanding the latest numbers, trends, and veterinary implications is critical for protecting animal health and managing outbreaks.
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
Zoetis Inc. announced that the European Commission has granted the company marketing authorization for Lenivia® (izenivetmab) for the reduction of pain associated with osteoarthritis (OA) in dogs.
Crazy Questions and Maple Madness: Shannon Gervais Faces Brain Smarts
Hold onto your stethoscopes, because Vet Candy’s Brain Smarts is back with an episode that’s equal parts trivia, chaos, and Canadian charm. This time, veterinary superstar Shannon Gervais is taking the hot seat—and she’s not just answering questions, she’s opening her very own vet clinic in Alberta, Canada- Nova Vet. Yep, she’s bringing her skills, smarts, and a little Maple Madness to the Great White North.
Zoetis : Acquires Veterinary Pathology Group to Strengthen Veterinary Diagnostics in UK and Ireland
Zoetis Inc. today announced the acquisition of Veterinary Pathology Group (VPG), a leading veterinary diagnostic laboratory group with multiple locations across the UK and Ireland. The acquisition further expands Zoetis' comprehensive diagnostics portfolio and reinforces its commitment to advancing animal health through innovative, high-quality diagnostic solutions.
Zoetis announced the launch of Vanguard Recombishield
Zoetis announced the U.S. launch of Vanguard® Recombishield™ (Bordetella bronchiseptica vaccine), a new injectable vaccine to protect against Bordetella bronchiseptica, also known as kennel cough. Licensed by the U.S. Department of Agriculture (USDA) on March 4, 2025, Recombishield is the first and only vaccine for dogs with pertactin protein for an optimized immune response. This innovation in Bordetella protection uses recombinant technology to provide a comfortable immunization experience for the pet, with minimal pain, swelling, stinging and sensitivity.
Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Portela® (relfovetmab), making it the first monoclonal antibody (mAb) therapy with a three-month dosing interval approved for the alleviation of pain associated with osteoarthritis (OA) in cats.